source
- Lilly’s retatrutide data at ADA 2026 underscores its lead in obesity drug marketThe American Diabetes Association’s 2026 meeting highlighted a wave of new weight‑loss drug data as companies vie for a slice of a market dominated by Eli Lilly and Novo Nordisk. Lilly presented r…
- J&J to buy Firefly Bio for $1 billion to boost KRAS inhibitor programJ&J announced Monday it will acquire biotech startup Firefly Bio for $1 billion, aiming to broaden its KRAS inhibitor portfolio. The move follows recent data from Revolution Medicines showing a KR…